<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Irwan ID</submitter><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</funding><funding>NIAID NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases</funding><funding>Duke | Center for AIDS Research, Duke University</funding><funding>Duke | Center for AIDS Research, Duke University (Duke University Center for AIDS Research)</funding><pagination>2101-2113</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9712108</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(12)</volume><pubmed_abstract>After viral entry and reverse transcription, HIV-1 proviruses that fail to integrate are epigenetically silenced, but the underlying mechanism has remained unclear. Using a genome-wide CRISPR/Cas9 knockout screen, we identified the host SMC5/6 complex as essential for this epigenetic silencing. We show that SMC5/6 binds to and then SUMOylates unintegrated chromatinized HIV-1 DNA. Inhibition of SUMOylation, either by point mutagenesis of the SMC5/6 component NSMCE2-a SUMO E3 ligase-or using the SUMOylation inhibitor TAK-981, prevents epigenetic silencing, enables transcription from unintegrated HIV-1 DNA and rescues the replication of integrase-deficient HIV-1. Finally, we show that blocking SMC5/6 complex expression, or inhibiting its SUMOylation activity, suppresses the establishment of l</pubmed_abstract><journal>Nature microbiology</journal><pubmed_title>Epigenetic silencing by the SMC5/6 complex mediates HIV-1 latency.</pubmed_title><pmcid>PMC9712108</pmcid><funding_grant_id>R21-AI157616</funding_grant_id><funding_grant_id>P30 AI064518</funding_grant_id><funding_grant_id>P30-AI064518</funding_grant_id><funding_grant_id>R21 AI157616</funding_grant_id><pubmed_authors>Cullen BR</pubmed_authors><pubmed_authors>Irwan ID</pubmed_authors><pubmed_authors>Bogerd HP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Epigenetic silencing by the SMC5/6 complex mediates HIV-1 latency.</name><description>After viral entry and reverse transcription, HIV-1 proviruses that fail to integrate are epigenetically silenced, but the underlying mechanism has remained unclear. Using a genome-wide CRISPR/Cas9 knockout screen, we identified the host SMC5/6 complex as essential for this epigenetic silencing. We show that SMC5/6 binds to and then SUMOylates unintegrated chromatinized HIV-1 DNA. Inhibition of SUMOylation, either by point mutagenesis of the SMC5/6 component NSMCE2-a SUMO E3 ligase-or using the SUMOylation inhibitor TAK-981, prevents epigenetic silencing, enables transcription from unintegrated HIV-1 DNA and rescues the replication of integrase-deficient HIV-1. Finally, we show that blocking SMC5/6 complex expression, or inhibiting its SUMOylation activity, suppresses the establishment of l</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-05-28T21:29:09.263Z</modification><creation>2025-04-19T22:50:15.94Z</creation></dates><accession>S-EPMC9712108</accession><cross_references><pubmed>36376394</pubmed><doi>10.1038/s41564-022-01264-z</doi></cross_references></HashMap>